Assistant: Pablo Lores Sylentis will participate as a sponsor More information: Home - 7th RNAi-Based Therapeutics Summit  

Further information: TIDES Asia: Oligonucleotide & Peptide Therapeutics Ana Isabel Jiménez and Pablo Lores will be representing Sylentis. Pablo will give two lectures: "Phase-appropriate CMC considerations for next generation oligonucleotides"

Further information: RNA Therapeutics & Vaccines | RNA Leaders Europe Pablo Lores will attend on behalf of Sylentis.

Further information: TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Sylentis is a sponsor Lola Company and Pablo Lores will attend, with the latter giving a talk entitled "Manufacturing Aspects o

Further information: HOME - IOPC Pablo Lores will attend on behalf of Sylentis.

Further information: IRT 2026 Sylentis is a sponsor Lola Company and Pablo Lores will attend on behalf of Sylentis